MENU
QUCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

QUCY stock forecast, quote, news & analysis

Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity... Show more

QUCY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
Aug 27, 2026

Why Quhuo (QUCY) Stock Is Up +26% in the Last 30 Days

Key Takeaways

  • Quhuo Limited (QUCY) shares rose roughly 26% over the trailing 30 days, rebounding from a late-July low near $1.09 to about $1.38 per share.
  • The advance follows a turbulent corporate restructuring, including a Nasdaq delisting dispute, a reverse ADS split, and the termination of the company's ADR program in favor of a direct listing of Class A ordinary shares.
  • Despite the 30-day gain, the stock remains sharply below its mid-May spike, down approximately 53% over the trailing quarter.
  • The rebound appears driven primarily by technical stabilization and unwinding selling pressure rather than a new earnings catalyst, with the next results expected around late September 2026.
  • As a micro-cap with thin liquidity, QUCY remains prone to outsized price swings in both directions.

Quhuo (QUCY) Company Overview and Market Position

Quhuo Limited is a Beijing-based gig economy platform focused on local life services in China. Founded in 2012 and listed on Nasdaq, the company provides tech-enabled, end-to-end operational solutions to consumer service businesses, anchored by its proprietary Quhuo+ technology infrastructure.

The business operates through three main segments: on-demand delivery solutions, which cover last-mile delivery of prepared food, grocery, and fresh food; mobility service solutions, including ride-hailing, shared-bike maintenance, and vehicle export; and housekeeping and accommodation solutions serving hotels and bed-and-breakfasts. On-demand delivery is by far the largest revenue contributor.

Investors follow QUCY both for its exposure to China's on-demand economy and for its corporate-governance and listing-status developments, which have dominated trading in the stock during 2026.

Quhuo (QUCY) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, QUCY climbed from a closing level of $1.09 on July 28, 2026, to approximately $1.38 by late August 2026, a gain of about 26%. The advance was not a straight line: the shares found a base in the $1.03–$1.14 range in late July before firming through August on generally rising sessions.

The longer-term picture is materially different. Over the trailing quarter, the stock has fallen roughly 53%, from about $2.93 in late May to its current level. This reflects the unwind of an earlier speculative surge, which pushed the shares from below $0.40 to an intraday peak above $4.90 in mid-May before a multi-week pullback. In short, the recent 30-day recovery remains well short of recapturing the quarter's losses.

What Drove QUCY Stock Price in the Last 30 Days

The 30-day advance appears to be a technical recovery rather than a response to a specific earnings or product catalyst. Several factors contributed to the stabilization and rebound:

  • Post-restructuring normalization. The completion of Quhuo's corporate reorganization — including the termination of its ADR program and the direct listing of consolidated Class A ordinary shares, effective in mid-July 2026 — reduced the overhang of structural uncertainty that had pressured the shares.
  • Unwinding selling pressure. Reported short interest declined markedly through the period, easing downward pressure and supporting the rebound from oversold levels.
  • Thin liquidity amplifies moves. With a small float and relatively low average trading volume, QUCY is susceptible to sharp percentage moves even without major news, making the 26% swing partly a function of the stock's micro-cap structure.

No company earnings release or major new operational announcement occurred within the 30-day window, underscoring that the move was driven primarily by positioning, liquidity, and sentiment normalization.

What Drove QUCY Stock Performance Over the Last Quarter

The quarterly story is dominated by Quhuo's listing-status crisis and its subsequent restructuring. In March 2026, Nasdaq issued a delisting determination after the company's ADSs traded at or below $0.10 for ten consecutive sessions, and trading was suspended in early April. Quhuo responded with a 1-for-30 reverse ADS split in late April, moved to the OTC market, and appealed the delisting decision.

The stock staged an explosive, highly volatile rally in mid-May as the company regained bid-price compliance and the Nasdaq Hearings Panel granted continued listing subject to conditions, including a transfer to the Nasdaq Capital Market. Those gains subsequently unwound over June and July as speculative momentum faded. The broader backdrop remains challenging: Quhuo reported a year-over-year revenue decline and a net loss for fiscal 2025, reflecting competitive and demand pressures in China's on-demand services market.

Trending AI Robots

For traders seeking a more systematic approach to volatile, event-driven names like QUCY, Tickeron's Trending AI Robots page offers a curated view of AI-powered trading tools. Tickeron provides hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, helping users cut through the noise. These bots vary widely in strategy, timeframe, and performance metrics, allowing traders to explore approaches aligned with different risk profiles and market conditions. Reviewing the section can offer a useful starting point for those interested in algorithm-driven signals.

QUCY Stock Forecast Drivers: What Investors Should Watch Next

Several factors will likely shape QUCY's trajectory in the coming months. The next earnings report, expected around late September 2026, will be closely watched for signs of stabilizing revenue and narrowing losses. Investors should also monitor the company's continued compliance with Nasdaq listing standards during the exchange's one-year monitoring period, as any lapse could trigger renewed delisting proceedings.

Other important considerations include the company's commitment to refrain from external financing, which limits near-term capital-raising flexibility; demand trends in China's on-demand delivery market; competitive pressures from larger platforms; and broader macroeconomic conditions affecting consumer spending. Given the stock's micro-cap status and elevated volatility, price movements may continue to be driven as much by liquidity and sentiment as by fundamentals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for QUCY with price predictions
Sep 11, 2026

QUCY in upward trend: 10-day moving average moved above 50-day moving average on August 26, 2026

The 10-day moving average for QUCY crossed bullishly above the 50-day moving average on August 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

QUCY moved above its 50-day moving average on August 26, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +8.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUCY advanced for three days, in 143 of 178 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 40 of 62 cases where QUCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QUCY as a result. In 96 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for QUCY turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

QUCY broke above its upper Bollinger Band on August 31, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating fairly steady price growth. QUCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.590) is normal, around the industry mean (60.137). P/E Ratio (0.000) is within average values for comparable stocks, (156.768). QUCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.504). QUCY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). QUCY's P/S Ratio (62.500) is very high in comparison to the industry average of (9.865).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 18.5B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -4%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 36%. BNR experienced the highest price growth at 8%, while BIAF experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -17%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 61
Price Growth Rating: 42
SMR Rating: 78
Profit Risk Rating: 90
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
QUCY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Details
Industry
N/A
Address
Robert Koch Strasse 50
Phone
+49 61315542860
Employees
13
Web
http://quantum-cyber.ai
Why Quhuo (QUCY) Stock Is Up +26% in the Last 30 Days